Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

BACKGROUND: Our purpose was to evaluate thymidine synthase (TS), thymidine phosphorylase (TP), and excision repair cross-complementation group 1 (ERCC1) expression as biomarkers for capecitabine and cisplatin (XP) combination chemotherapy in patients with metastatic oesophageal squamous cell cancer....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, S, Park, Y H, Kim, K H, Cho, E Y, Ahn, Y C, Kim, K, Shim, Y-M, Ahn, J S, Park, K, Im, Y-H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2010
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2966625/
https://ncbi.nlm.nih.gov/pubmed/20700125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605831
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados